• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROGAV 2.0 VALVE; PREVIOUSLY REPORTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROGAV 2.0 VALVE; PREVIOUSLY REPORTED Back to Search Results
Model Number FX410T
Device Problems Defective Component (2292); Appropriate Term/Code Not Available (3191)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/05/2020
Event Type  Injury  
Manufacturer Narrative
If follow-up information/evaluation results are received, a supplemental report will be provided.
 
Event Description
It was reported that there was an issue with a prosa and progav 2.0 shuntsystem.The reporter indicated that there the valves were explanted.The valves had been initially implanted on an unspecified date, possibly at a different health care facility.A surgeon attempted to adjust the prosa valve from 12 to 14.Verified 12 setting and after adjustment valve went to 0.Attempted several times to move valve back to 14 and it was not moving from 0 setting.The surgeon made the decision to explant valves and implant a competitor's product.Additional information has been requested.Associated medwatches: 2916714-2020-00194.
 
Manufacturer Narrative
Updated information: b5 d section - serial and lot #, expiration date, explant date, manufacture date 03/30/2016 patient height 4'8 ft.Associated medwatches: 2916714-2020-00191, 2916714-2020-00194.Visual inspection: we have checked for possible damages, deformations of the housing or other abnormalities.The following observations were made during the visual inspection: deposits in the outlet spout.Permeability test: this test is carried out with the product in the horizontal position with a hydrostatic pressure difference of approx.30 cmh2o in the direction of flow.The test showed that the progav 2.0 is permeable.Adjustability test: thus indicating whether the valve is fully adjustable within the full range of specified pressure settings (in increments of 5 cmh2o).The progav 2.0 was found to be adjustable to all pressure settings.Braking force and brake function test a specific measurement device apparatus of braking force is used to investigate the braking force and the brake function of adjustable valves.This apparatus tests whether the braking function is present and how much force must be exerted on the housing to release the rotor to adjust the valve using the integrated magnet of the braking force apparatus.The braking force of the progav 2.0 was within the specified tolerance and the brake function operated as expected.After dismantling of the valve, slightly deposits were found in progav 2.0.Based on our investigation, we are not able to substantiate the claim of "programming issues".At the time of the investigation, it is not clear to us how the mentioned functional impairment occurred.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of non-visible deposits might compromise the integrity of the valve.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.From our point of view, no further regulatory actions are required.
 
Event Description
Updates provided: implantation: 2017; removal: (b)(6) 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 VALVE
Type of Device
PREVIOUSLY REPORTED
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
MDR Report Key10164671
MDR Text Key195990152
Report Number2916714-2020-00191
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup
Report Date 06/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/23/2021
Device Model NumberFX410T
Device Catalogue NumberFX410T
Device Lot Number20029842
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/15/2020
Was the Report Sent to FDA? No
Distributor Facility Aware Date06/15/2020
Event Location Hospital
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age12 YR
Patient Weight37
-
-